Company Filing History:
Years Active: 2011
Title: Jürgen Boer - Innovator in Dipeptidyl Peptidase-IV Inhibitors
Introduction
Jürgen Boer is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit dipeptidyl peptidase-IV (DPP-IV). His work is particularly relevant for the treatment of Type-2 diabetes.
Latest Patents
Jürgen Boer holds a patent for "Dipeptidyl peptidase-IV inhibitors." This invention relates to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The patent also outlines synthetic methods for preparing these compounds, methods for inhibiting DPP-IV using them, and pharmaceutical formulations that contain these compounds for treating DPP-IV mediated diseases.
Career Highlights
Throughout his career, Jürgen Boer has worked with prominent companies in the pharmaceutical industry. He has been associated with Amgen Inc. and Alantos Pharmaceuticals Holding, Inc., where he has contributed to various innovative projects.
Collaborations
Jürgen Boer has collaborated with notable professionals in his field, including Heiko Kroth and Tim Feuerstein. These collaborations have further enhanced his research and development efforts.
Conclusion
Jürgen Boer is a distinguished inventor whose work on DPP-IV inhibitors has the potential to impact the treatment of Type-2 diabetes significantly. His contributions to the pharmaceutical industry reflect his commitment to innovation and improving healthcare outcomes.